ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. - Wikidata - awgldk - TriplyDB

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

http://www.wikidata.org/entity/Q48510594

about

Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies Molecular Genetics of Epilepsy: A Clinician's Perspective.Polymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance - preliminary results.MDR-1 and MRP2 Gene Polymorphisms in Mexican Epileptic Pediatric Patients with Complex Partial Seizures Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis.Imaging of multidrug resistance in cancer ABCB1 gene C3435T polymorphism and drug resistance in epilepsy: evidence based on 8,604 subjects.Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.The adverse effects of antiepileptic drugs in children.Antiepileptic medication during pregnancy: does fetal genotype affect outcome?Multidrug resistance in epilepsy: a pharmacogenomic update.CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERG.The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.Predicting potentially functional SNPs in drug-response genes.Epilepsy pharmacogenetics.Genetic Variations of ABCC2 Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic Patients Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients.Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population.Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis.Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective.Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions.Development of individualized medicine for epilepsy based on genetic information.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Biomarkers for antiepileptic drug response.Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.Association between ABCB1 polymorphisms and response to First-generation antiepileptic drugs in a Tunisian epileptic population.Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy.Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese.Association of ABCB1 C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy.Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting.

P2860

Q28533307-F9C33EE1-DAE4-4524-B07F-56F365AD1E1C Q28540047-A1E8E7BF-1B2C-4457-9C06-7C8FFEB50F66 Q28545116-AB982BCB-2ED6-4047-9B6B-F5E2ED989348 Q33795557-6724A5C9-71E4-4628-B26A-92B10C233C53 Q34237989-77FA4FF7-D4E1-444E-9E5D-8803E94EBAD8 Q34312249-C5EFED13-9082-4BE4-8E58-04729DFD3ADC Q34769781-BABC62E4-E384-41F4-BB7E-C60FE451BDA5 Q34823564-25A2087A-BA39-464C-8489-186A31EDCC57 Q35280616-548D985D-5EB5-4E13-836B-53A5638B898C Q35837256-DF211B07-4A73-4185-A1BB-F0B4C55D30B3 Q36281662-ED10D956-9F93-4AA6-BD14-E1A1CBBA5C1C Q36803428-668B7127-9FC4-4990-A009-45B349E66A89 Q36811532-1388C3C9-D4F9-40B0-BCD3-0D24D03763A3 Q36863422-E88A48C6-6870-41B0-B98B-E9D5F5A8C6CE Q36895830-3C092E3C-DC36-4A69-BDA6-ABF7CE3EA78B Q37104987-7BE8456B-7A0B-43ED-9887-8C914F6A55A1 Q37178631-F9F4763E-9AC1-4B98-9B0A-FA2B85210D57 Q37423761-CD08C85C-36DE-49E0-BC76-E1FA49FEDB05 Q37448909-BE46098C-092D-4E77-8693-0D3D9F4CCEBA Q37486720-FB851E12-2DAC-4076-93AF-09A73B2558A3 Q37500912-FCF8C296-DE40-4686-BA81-3B2148A6CE3F Q37522302-C2765BBB-0732-43A6-890E-9F1B56513D69 Q37626601-625236E8-EC12-43E5-83DD-549B55EBC066 Q37806763-922B273F-DB17-4BE6-ABD7-D97471F79AA7 Q37851513-956F7B38-D8EE-4B87-A4CB-6325FF6E385B Q37900131-CE05C38B-B72C-4BF2-9643-3F74BE1C8BA0 Q38160088-FD073112-C6ED-44F4-8A2F-D6CF7C9FA06D Q38178326-1CD5C919-CF0E-4586-84EE-9B2437446496 Q38181565-E6AA9BF3-6A93-4309-9B1C-A7A2AA7AA9E9 Q38243832-D9067ED8-9135-4F5A-A4C1-AFAA18B96F64 Q38414396-5739924A-E056-41D0-AF26-5CD161146B59 Q40575037-65227D3C-CDCA-4F55-9A3B-2EE35B14A424 Q41704645-730AB45F-FAE7-4815-90C2-8CAAA3D6A752 Q42985589-CF3DD401-972C-459D-A434-DC8DBBD84DCF Q43903895-DABD2F78-CCD8-49C1-991D-057019555F6B Q46537046-07B8A787-F170-40A0-BCB0-0E867E15538A Q46605318-C8F87329-D4FE-463F-9C79-BA851F9596E5 Q47778592-3DA51F91-97FC-4923-98AA-299258DFB3EA Q49118555-265ACA5A-FABE-4273-917C-428CEE2B8D2A Q51347270-62F85D66-C1A5-4066-9A2B-3BEA6D1DDF4D

P2860

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

http://www.wikidata.org/entity/Q48510594

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@en

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@nl

type

label

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@en

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@nl

prefLabel

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@en

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@nl

P1433

Q48510594-23DAC563-ABD3-4906-BE3E-604019BA1695

P1476

Q48510594-D41318B8-8272-4D61-8B50-E12C1E2A6931

P2093

Q48510594-2128DDEB-3F4D-4CF6-BE7C-426BC424E10D

Q48510594-41084153-9C97-4CEC-A866-78250DCCF2BD

Q48510594-668E9042-BFB6-4032-A481-45EBF0C8C9F0

Q48510594-92D5F27E-98C8-46E6-AF6D-E55080064E98

Q48510594-95C36165-5D0A-45F6-9F52-85D38338C3C6

Q48510594-CBD85DC7-2A65-4FD3-86F2-6DD750078548

Q48510594-D1303C87-1894-491E-8A76-7236DF4D2E7E

P2860

Q48510594-07C45000-2161-4C8B-BDA2-2F2C8F3C39C0

Q48510594-0D2C4DFF-709A-427C-945E-F4D460895E83

Q48510594-0E426189-F343-43EC-AA82-890451B7873A

Q48510594-1C36A2D6-67CA-4526-92F4-23900309AD8D

Q48510594-222B049A-5DEA-4682-A883-6BE0D4DB6F21

Q48510594-359F498F-97ED-41BC-AF5B-57CACFDA2A0D

Q48510594-36AD2C1F-EF49-4174-B4AD-A530A444B4BD

Q48510594-42483C1E-597A-48C9-BB1D-78BA2BC1A748

Q48510594-4D79D9A9-F129-43A7-AE46-BADE3BB4536F

Q48510594-4EC1FEA3-8959-4647-94E0-C890F903A748

P304

Q48510594-2BE49ABF-1D66-4C93-A9BF-950C9A698251

P31

Q48510594-1B9D684A-D997-40BB-BF18-5F9B93F80A16

P356

Q48510594-5E5E0D60-915B-4962-8935-753443E6B1C3

P433

Q48510594-B50FB06D-3BBB-4A69-B51D-EB6191C484B7

P478

Q48510594-E78CA570-43CF-4C27-808E-1575C0AF7B61

P577

Q48510594-6177E247-EC43-4BAF-8F87-CBDE682BBF37

P5875

Q48510594-97781B21-96CA-4C01-82D8-0FF44E428409

P698

Q48510594-A7D4D5B7-CCA0-4FB8-9A68-111EC4BC27A8

P921

Q48510594-2E6C1B4E-4177-4931-8F09-982CEFB37B4D

P356

14622416.7.4.551

P1433

Pharmacogenomics

P1476

ABCB1 polymorphisms influence ...... in Japanese epilepsy patients.

@en

P2093

Kazuko Nakagawa

http://www.w3.org/2001/XMLSchema#string

Keigo Yurube

http://www.w3.org/2001/XMLSchema#string

Kentaro Ueda

http://www.w3.org/2001/XMLSchema#string

Nao Ueda

http://www.w3.org/2001/XMLSchema#string

Naoyuki Nakada

http://www.w3.org/2001/XMLSchema#string

Takateru Ishitsu

http://www.w3.org/2001/XMLSchema#string

Takayuki Seo

http://www.w3.org/2001/XMLSchema#string

P2860

Early identification of refractory epilepsy

Carbamazepine is not a substrate for P-glycoprotein

Drug resistance in brain diseases and the role of drug efflux transporters.

MDR1 gene expression in brain of patients with medically intractable epilepsy.

The genetic polymorphism of drug transporters: functional analysis approaches.

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.

Importance of P-glycoprotein at blood-tissue barriers.

Genetic association studies in epilepsy: "the truth is out there".

Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.

P304

551-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.7.4.551

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7030017

http://www.w3.org/2001/XMLSchema#string

P698

16753003

http://www.w3.org/2001/XMLSchema#string

P921